Overview

This trial is active, not recruiting.

Condition infertility
Treatment in-vitro fertilization using eeva
Sponsor Auxogyn, Inc.
Start date February 2013
End date June 2015
Trial size 1200 participants
Trial identifier NCT01816802, 2012-AUX-009, TST 2193-p

Summary

The purpose of this study is to record and evaluate the use of traditional morphology grading combined with Eeva in the treatment of in vitro fertilization.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
Patients undergoing in-vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.
in-vitro fertilization using eeva
Eeva will image embryos through cleavage stage (Day 3). Embryologists will use Eeva results along with traditional morphological grading to assist in selecting embryo(s) for transfer or freezing.

Primary Outcomes

Measure
Clinical Pregnancy Rate
time frame: 5-6 gestational weeks

Eligibility Criteria

Female participants of any age.

Inclusion Criteria: - women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs. Exclusion Criteria: - history of cancer. - gestational carrier.

Additional Information

Official title MERGE: MulticEnter ReGistry With Eeva
Description This is a prospective, observational, single-arm, nonrandomized, multicenter study. Data will be collected to establish eligibility, at baseline, during the stimulation and in vitro fertilization process, during embryo culture, at embryo transfer, at 12-18 days post egg retrieval to verify biochemical pregnancy, and then typically at 5-6 weeks gestational weeks to verify clinical pregnancy.
Trial information was received from ClinicalTrials.gov and was last updated in March 2015.
Information provided to ClinicalTrials.gov by Auxogyn, Inc..